2020
DOI: 10.18773/austprescr.2020.050
|View full text |Cite
|
Sign up to set email alerts
|

Real-time prescription monitoring: helping people at risk of harm

Abstract: Misuse of opioid analgesics and other psychoactive medicines is a serious and increasing problem in Australia. Measures are being taken to try and prevent this progressing to a public health crisis like the opioid overdose epidemic seen in the USA. One measure is real-time prescription monitoring. This provides real-time information about the patient's supply of psychoactive medicines which have a high risk of being misused. Having identified a patient at risk, many factors may delay appropriate management or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 9 publications
(9 citation statements)
references
References 27 publications
0
9
0
Order By: Relevance
“…Other interventions may also help reduce the number of BZD prescriptions sought by patients and prescribed by GPs, such as reducing pack sizes where possible, increasing the availability of non-drug interventions for insomnia management 45 , and introducing real-time prescription monitoring to identify patients who visit multiple doctors for scripts. 46 S2: Benzodiazepines, z-drugs, and non-benzodiazepines prescription (total number of prescriptions and crude rates per 1,000 consultations) among patients regularly attending Australian general practice, 2011-2018 Supplementary Table S3: proportion of incident prescriptions of benzodiazepines, z-drugs and non-benzodiazepines with an incident insomnia diagnosis among patients attending general practice every-year from 2011-2018 Supplementary Figure S1: Proportion of overall benzodiazepines, z-drugs and nonbenzodiazepines scripts, written with more repeats than recommended by guidelines. Australian general practices, 2011-2018 * Results adjusted for age, sex.…”
Section: Implications For Research And/or Practicementioning
confidence: 99%
“…Other interventions may also help reduce the number of BZD prescriptions sought by patients and prescribed by GPs, such as reducing pack sizes where possible, increasing the availability of non-drug interventions for insomnia management 45 , and introducing real-time prescription monitoring to identify patients who visit multiple doctors for scripts. 46 S2: Benzodiazepines, z-drugs, and non-benzodiazepines prescription (total number of prescriptions and crude rates per 1,000 consultations) among patients regularly attending Australian general practice, 2011-2018 Supplementary Table S3: proportion of incident prescriptions of benzodiazepines, z-drugs and non-benzodiazepines with an incident insomnia diagnosis among patients attending general practice every-year from 2011-2018 Supplementary Figure S1: Proportion of overall benzodiazepines, z-drugs and nonbenzodiazepines scripts, written with more repeats than recommended by guidelines. Australian general practices, 2011-2018 * Results adjusted for age, sex.…”
Section: Implications For Research And/or Practicementioning
confidence: 99%
“…Up-scheduling medicines to prescription only and legislating stricter therapeutic indications can reduce access to toxic medicines. On a patient level, real-time prescription monitoring has been implemented in many parts of the world and should be used by health care practitioners to help reduce problematic medicine misuse . Patients with identified suicide risks should be prescribed the less toxic agents as first-line treatment (ie, SSRIs in preference to TCAs) or treatments such as long-acting antipsychotic depot injections, which remove the means for self-poisoning.…”
Section: Discussionmentioning
confidence: 99%
“…The states and territories have been adopting real-time prescription monitoring system which provides the patient history of opioid prescriptions to prescribers, to prevent people with multiple prescribers to obtain excessive amount of opioid medications. The effectiveness of the prescribing monitoring system remains uncertain [10,11], with concerns over unintended stigmatisation of patients which may jeopardise their treatments [10]. Further assessment and improvement are needed to enhance patient outcome and safety.…”
Section: Discussionmentioning
confidence: 99%